Rao L V, Nordfang O, Hoang A D, Pendurthi U R
Department of Biochemistry, University of Texas Health Center at Tyler 75710.
Blood. 1995 Jan 1;85(1):121-9.
Recent studies have shown that antithrombin III (AT III)/heparin is capable of inhibiting the catalytic activity of factor VIIa bound either to relipidated tissue factor (TF) in suspension or to TF expressed on cell surfaces. We report studies of the mechanism of which by AT III inhibits factor VIIa bound to cell surface TF and compare this inhibitory mechanism with that of tissue factor pathway inhibitor (TFPI)-induced inhibition of factor VIIa/TF. AT III alone and AT III/heparin to a greater extent reduced factor VIIa bound to cell surface TF. Our data show that the decrease in the amount of factor VIIa associated with cell surface TF in the presence of AT III was the result of (1) accelerated dissociation of factor VIIa from cell surface TF after the binding of AT III to factor VIIa/TF complexes and (2) the inability of the resultant free factor VIIa-AT III complexes to bind effectively to a new cell surface TF site. Binding of TFPI/factor Xa to cell surface factor VIIa/TF complexes markedly decreased the dissociation of factor VIIa from the resultant quaternary complex of factor VIIa/TF/TFPI/factor Xa. Addition of high concentrations of factor VIIa could reverse the AT III-induced inhibition of cell surface factor VIIa/TF activity but not TFPI/factor Xa-induced inhibition of factor VIIa/TF activity.
近期研究表明,抗凝血酶III(AT III)/肝素能够抑制与悬浮液中再脂化组织因子(TF)或细胞表面表达的TF结合的因子VIIa的催化活性。我们报告了关于AT III抑制与细胞表面TF结合的因子VIIa的机制的研究,并将这种抑制机制与组织因子途径抑制剂(TFPI)诱导的对因子VIIa/TF的抑制作用进行比较。单独的AT III以及更大程度上的AT III/肝素减少了与细胞表面TF结合的因子VIIa。我们的数据表明,在存在AT III的情况下,与细胞表面TF相关的因子VIIa量的减少是以下结果:(1)AT III与因子VIIa/TF复合物结合后,因子VIIa从细胞表面TF加速解离;(2)由此产生的游离因子VIIa-AT III复合物无法有效地结合到新的细胞表面TF位点。TFPI/因子Xa与细胞表面因子VIIa/TF复合物的结合显著降低了因子VIIa从因子VIIa/TF/TFPI/因子Xa的最终四聚体复合物中的解离。添加高浓度的因子VIIa可以逆转AT III诱导的对细胞表面因子VIIa/TF活性的抑制,但不能逆转TFPI/因子Xa诱导的对因子VIIa/TF活性的抑制。